Recommended indications for the administration of polyclonal immunoglobulin preparations

Delforge, M; Farber, C M; Spath, P; Kaveri, S; Witte, T; Misbah, S A; Hübner, R; Haerynck, F; Latinne, D; Muylle, L; Toungouz, M; Deneys, V; Superior Health Council Belgium, (2011). Recommended indications for the administration of polyclonal immunoglobulin preparations. Acta clinica belgica, 66(5), pp. 346-60. Brussels: Acta clinica belgica 10.2143/ACB.66.5.2062586

Full text not available from this repository. (Request a copy)

The following recommendations, which aim at standardising and rationalising the clinical indications for administering polyclonal immunoglobulins in Belgium, were drawn up by a working group of the Superior Health Council. To this end, the Superior Health Council organised an expert meeting devoted to"Guidelines for the use of immunoglobulins". The experts discussed the indications for immunoglobulin use, the'ideal'immunoglobulin preparation, its mechanisms of action, the practical issues involved in administering immunoglobulins and their potential side effects. The recommendations formulated by the experts were validated by the Superior Health Council working group with the purpose of harmonising immunoglobulin use in Belgium

Item Type:

Journal Article (Further Contribution)


04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Späth, Peter Julius




Acta clinica belgica




Factscience Import

Date Deposited:

04 Oct 2013 14:18

Last Modified:

17 Mar 2015 19:23

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 210267)

Actions (login required)

Edit item Edit item
Provide Feedback